# Correction: Genetic analysis of IFNG-AS1 implicates opposite effects to Leishmania guyanensis-cutaneous leishmaniasis: rs4913269 confers protection while rs7134599 enhances susceptibility and correlates with high plasma IL-4 and IL-10 levels

**Authors:** Marcus Vinitius de Farias Guerra, Josué Lacerda de Souza, Lener Santos da Silva, José do Espírito Santo Júnior, Tirza Gabrielle Ramos de Mesquita, Krys Layane Guimarães, Duarte Queiroz, George Allan Villarouco da Silva, Mauricio Morishi Ogusku, Mara Lúcia Gomes de Souza, José Pereira de Moura Neto, Aya Sadahiro, Rajendranath Ramasawmy

PMC · DOI: 10.1371/journal.pntd.0013656 · 2025-10-30

## Full-text entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, IFNG-AS1 (IFNG regulatory antisense RNA 1) [NCBI Gene 100885789] {aka GS1-410F4.2, NEST, Tmevpg1}
- **Diseases:** cutaneous leishmaniasis (MESH:D016773), Leishmania guyanensis (MESH:D007896)
- **Mutations:** rs7134599, rs4913269

---
Source: https://tomesphere.com/paper/PMC12574835